» Articles » PMID: 22872811

Telomere Lengthening and Other Functions of Telomerase

Overview
Journal Acta Naturae
Specialty Biology
Date 2012 Aug 9
PMID 22872811
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Telomerase is an enzyme that maintains the length of the telomere. The telomere length specifies the number of divisions a cell can undergo before it finally dies (i.e. the proliferative potential of cells). For example, telomerase is activated in embryonic cell lines and the telomere length is maintained at a constant level; therefore, these cells have an unlimited fission potential. Stem cells are characterized by a lower telomerase activity, which enables only partial compensation for the shortening of telomeres. Somatic cells are usually characterized by the absence of telomerase activity. Telomere shortening leads to the attainment of the Hayflick limit, the transition of cells to a state of senescence. The cells subsequently enter a state of crisis, accompanied by massive cell death. The surviving cells become cancer cells, which are capable both of dividing indefinitely and maintaining telomere length (usually with the aid of telomerase). Telomerase is a reverse transcriptase. It consists of two major components: telomerase RNA (TER) and reverse transcriptase (TERT). TER is a non-coding RNA, and it contains the region which serves as a template for telomere synthesis. An increasing number of articles focussing on the alternative functions of telomerase components have recently started appearing. The present review summarizes data on the structure, biogenesis, and functions of telomerase.

Citing Articles

Immune response accelerated telomere shortening during early life stage of a passerine bird, the blue tit ().

Schiavinato M, Ronanki S, Estruch I, van den Brink N Biol Lett. 2025; 21(1):20240618.

PMID: 39837488 PMC: 11750392. DOI: 10.1098/rsbl.2024.0618.


Oxidative Stress, Telomere Length and Telomerase Activity in Spermatogenesis Disorders (Review of Scientific Activity).

Kurashova N, Dashiev B, Kolesnikov S, Kolesnikova L Bull Exp Biol Med. 2024; 176(2):115-122.

PMID: 38189870 DOI: 10.1007/s10517-024-05979-3.


Tankyrase: a promising therapeutic target with pleiotropic action.

Sagathia V, Patel C, Beladiya J, Patel S, Sheth D, Shah G Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(12):3363-3374.

PMID: 37338576 DOI: 10.1007/s00210-023-02576-5.


Lipoprotein Particle Profiles Associated with Telomere Length and Telomerase Complex Components.

Novau-Ferre N, Rojas M, Gutierrez-Tordera L, Arcelin P, Folch J, Papandreou C Nutrients. 2023; 15(11).

PMID: 37299586 PMC: 10255183. DOI: 10.3390/nu15112624.


Expandable Lung Epithelium Differentiated from Human Embryonic Stem Cells.

Kotasova H, Capandova M, Pelkova V, Dumkova J, Koledova Z, Remsik J Tissue Eng Regen Med. 2022; 19(5):1033-1050.

PMID: 35670910 PMC: 9478014. DOI: 10.1007/s13770-022-00458-0.


References
1.
Loayza D, de Lange T . POT1 as a terminal transducer of TRF1 telomere length control. Nature. 2003; 423(6943):1013-8. DOI: 10.1038/nature01688. View

2.
Dragon F, Pogacic V, Filipowicz W . In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs. Mol Cell Biol. 2000; 20(9):3037-48. PMC: 85579. DOI: 10.1128/MCB.20.9.3037-3048.2000. View

3.
Gallardo F, Laterreur N, Cusanelli E, Ouenzar F, Querido E, Wellinger R . Live cell imaging of telomerase RNA dynamics reveals cell cycle-dependent clustering of telomerase at elongating telomeres. Mol Cell. 2011; 44(5):819-27. DOI: 10.1016/j.molcel.2011.09.020. View

4.
Girard C, Verheggen C, Neel H, Cammas A, Vagner S, Soret J . Characterization of a short isoform of human Tgs1 hypermethylase associating with small nucleolar ribonucleoprotein core proteins and produced by limited proteolytic processing. J Biol Chem. 2007; 283(4):2060-9. DOI: 10.1074/jbc.M704209200. View

5.
Hisatomi H, Ohyashiki K, Ohyashiki J, Nagao K, Kanamaru T, Hirata H . Expression profile of a gamma-deletion variant of the human telomerase reverse transcriptase gene. Neoplasia. 2003; 5(3):193-7. PMC: 1502410. DOI: 10.1016/S1476-5586(03)80051-9. View